199 related articles for article (PubMed ID: 7618162)
21. Functional significance of different human CYP1A1 genotypes.
Crofts F; Taioli E; Trachman J; Cosma GN; Currie D; Toniolo P; Garte SJ
Carcinogenesis; 1994 Dec; 15(12):2961-3. PubMed ID: 8001264
[TBL] [Abstract][Full Text] [Related]
22. A population genetics study of single nucleotide polymorphisms in the interleukin 4 receptor alpha (IL4RA) gene.
Wu X; Di Rienzo A; Ober C
Genes Immun; 2001 May; 2(3):128-34. PubMed ID: 11426321
[TBL] [Abstract][Full Text] [Related]
23. Special report: genotyping for cytochrome P450 polymorphisms to determine drug-metabolizer status.
Technol Eval Cent Assess Program Exec Summ; 2004 Dec; 19(9):1-2. PubMed ID: 15651132
[No Abstract] [Full Text] [Related]
24. Ethnic-related differences in the frequency distribution of genetic polymorphisms in the CYP1A1 and CYP1B1 genes in Japanese and Caucasian populations.
Inoue K; Asao T; Shimada T
Xenobiotica; 2000 Mar; 30(3):285-95. PubMed ID: 10752643
[TBL] [Abstract][Full Text] [Related]
25. Susceptibility to lung cancer in light smokers associated with CYP1A1 polymorphisms in Mexican- and African-Americans.
Ishibe N; Wiencke JK; Zuo ZF; McMillan A; Spitz M; Kelsey KT
Cancer Epidemiol Biomarkers Prev; 1997 Dec; 6(12):1075-80. PubMed ID: 9419406
[TBL] [Abstract][Full Text] [Related]
26. Identification of novel polymorphisms in the 5' flanking region of CYP1A2, characterization of interethnic variability, and investigation of their functional significance.
Aitchison KJ; Gonzalez FJ; Quattrochi LC; Sapone A; Zhao JH; Zaher H; Elizondo G; Bryant C; Munro J; Collier DA; Makoffa AI; Kerwin RW
Pharmacogenetics; 2000 Nov; 10(8):695-704. PubMed ID: 11186132
[TBL] [Abstract][Full Text] [Related]
27. Ethnic differences in CD1E, but not CD1A, gene polymorphisms between Sub-Saharan Africans, West Asians and Europeans.
Mombo LE; Ramasawmy R; Zertal-Zidani S; Charron D; Tamouza R
Hum Immunol; 2019 Mar; 80(3):204-207. PubMed ID: 30576703
[TBL] [Abstract][Full Text] [Related]
28. Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population.
Gaikovitch EA; Cascorbi I; Mrozikiewicz PM; Brockmöller J; Frötschl R; Köpke K; Gerloff T; Chernov JN; Roots I
Eur J Clin Pharmacol; 2003 Aug; 59(4):303-12. PubMed ID: 12879168
[TBL] [Abstract][Full Text] [Related]
29. Cytochrome P450 pharmacogenetics in African populations: implications for public health.
Dandara C; Swart M; Mpeta B; Wonkam A; Masimirembwa C
Expert Opin Drug Metab Toxicol; 2014 Jun; 10(6):769-85. PubMed ID: 24588448
[TBL] [Abstract][Full Text] [Related]
30. Single-nucleotide polymorphisms in tumor necrosis factor receptor genes: definition of novel haplotypes and racial/ethnic differences.
Bridges SL; Jenq G; Moran M; Kuffner T; Whitworth WC; McNicholl J
Arthritis Rheum; 2002 Aug; 46(8):2045-50. PubMed ID: 12209507
[TBL] [Abstract][Full Text] [Related]
31. Failure to find exon 7 polymorphism of the ADH7 gene in Chinese, Japanese, African-Americans, and Caucasians.
Carr LG; Zeng D; Li TK
Alcohol Clin Exp Res; 1996 May; 20(3):418-9. PubMed ID: 8727230
[TBL] [Abstract][Full Text] [Related]
32. Lung cancer risk in relation to the CYP2E1 Rsa I genetic polymorphism among African-Americans and Caucasians in Los Angeles County.
London SJ; Daly AK; Cooper J; Carpenter CL; Navidi WC; Ding L; Idle JR
Pharmacogenetics; 1996 Apr; 6(2):151-8. PubMed ID: 9156693
[TBL] [Abstract][Full Text] [Related]
33. Genetic polymorphisms in MDR1 and CYP3A5 and MDR1 haplotype in mainland Chinese Han, Uygur and Kazakh ethnic groups.
Li D; Zhang GL; Lou YQ; Li Q; Wang X; Bu XY
J Clin Pharm Ther; 2007 Feb; 32(1):89-95. PubMed ID: 17286792
[TBL] [Abstract][Full Text] [Related]
34. Gene conversion and different population histories may explain the contrast between polymorphism and linkage disequilibrium levels.
Frisse L; Hudson RR; Bartoszewicz A; Wall JD; Donfack J; Di Rienzo A
Am J Hum Genet; 2001 Oct; 69(4):831-43. PubMed ID: 11533915
[TBL] [Abstract][Full Text] [Related]
35. Impact of CYP4F2 rs2108622 on the stable warfarin dose in an admixed patient cohort.
Perini JA; Struchiner CJ; Silva-Assunção E; Suarez-Kurtz G
Clin Pharmacol Ther; 2010 Apr; 87(4):417-20. PubMed ID: 20182420
[TBL] [Abstract][Full Text] [Related]
36. Genetic polymorphism of cytochrome P450 CYP2D6 in Zimbabwean population.
Masimirembwa CM; Johansson I; Hasler JA; Ingelman-Sundberg M
Pharmacogenetics; 1993 Dec; 3(6):275-80. PubMed ID: 7908586
[TBL] [Abstract][Full Text] [Related]
37. Detection of CYP1A1 gene polymorphism using designed RFLP and distributions of CYP1A1 genotypes in Japanese.
Oyama T; Mitsudomi T; Kawamoto T; Ogami A; Osaki T; Kodama Y; Yasumoto K
Int Arch Occup Environ Health; 1995; 67(4):253-6. PubMed ID: 7591186
[TBL] [Abstract][Full Text] [Related]
38. Geographic and racial/ethnic differences in HFE mutation frequencies in the Hemochromatosis and Iron Overload Screening (HEIRS) Study.
Acton RT; Barton JC; Snively BM; McLaren CE; Adams PC; Harris EL; Speechley MR; McLaren GD; Dawkins FW; Leiendecker-Foster C; Holup JL; Balasubramanyam A;
Ethn Dis; 2006; 16(4):815-21. PubMed ID: 17061732
[TBL] [Abstract][Full Text] [Related]
39. Population differences in DNA sequence variation and linkage disequilibrium at the PON1 gene.
Koda Y; Tachida H; Soejima M; Takenaka O; Kimura H
Ann Hum Genet; 2004 Mar; 68(Pt 2):110-9. PubMed ID: 15008790
[TBL] [Abstract][Full Text] [Related]
40. CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study.
Wenzlaff AS; Cote ML; Bock CH; Land SJ; Santer SK; Schwartz DR; Schwartz AG
Carcinogenesis; 2005 Dec; 26(12):2207-12. PubMed ID: 16051642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
